The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Reasons for Study
The use of Reason for Study (OBR-31) is required to capture the primary reason for testing. The following table lists the Reason for Study value set (Please note that this is a locally defined value set):
Value | Description | Value Set | Comments |
RFS01 | Diagnosis | BOL_0001 | Test ordered to diagnose illness. |
RFS02 | Outbreak | BOL_0001 | Indicate suspect agent responsible for a potential outbreak. Other information may be required when using this option including: Onset date, outbreak identifier, organism suspected and, if applicable, MDHHS prior approval. These additional items are sent as AOE OBXs. See Section 3.1.2 of the Lab Orders Implementation Guide. |
RFS03 | Surveillance | BOL_0001 | Indicate which study to which this sample is to be included. The Surveillance Study is sent in an AOE OBX with the code of AOE50. See Section 3.1.2 of the Lab Orders Implementation Guide. |
RFS05 | Symptoms | BOL_0001 | Patient requesting examination due to symptoms, or, symptoms discovered upon examination. |
RFS08 | Retest | BOL_0001 | Patients diagnosed with chlamydia and gonorrhea should be retested approximately three months after treatment, regardless of whether they believe that their sex partners were treated. If retesting at three months is not possible, clinicians should retest whenever that person next presents for medical care in the twelve months following initial treatment. |
RFS10 | Infected Partner | BOL_0001 | Patient has known exposure to a sexually transmitted disease (STD). This exposure may be self-reported or documented. |
RFS12 | Court Order | BOL_0001 | |
RFS13 | PrEP | BOL_0001 | Test is run in accordance with CDC Guidelines for prescribing and monitoring a patient on Pre-Exposure Prophylaxis for HIV (PrEP). |
RFS14 | PrEP - First Visit | BOL_0001 | Visit that initiates PrEP prescription; considered initial visit if medication is newly prescribed (e.g. not a refill). |
RFS15 | PrEP - Follow-up Visit | BOL_0001 | PrEP follow-up visit associated with routine monitoring of PrEP patient and refill of PrEP prescription. |
The following are used only for chlamydia/gonorrhea/trichomonas non-culture test requests:
Value | Description | Value Set | Comments |
RFS06 | History of STD (<3years) | BOL_0001 | Patient has been diagnosed with a sexually transmitted disease within the last three years. |
RFS07 | Age Recommended for Testing | BOL_0001 | The Centers for Disease Control (CDC) recommends annual screening of females <= 24 years of age. |
RFS09 | Partner Risk | BOL_0001 | Patient has multiple sex partners. |
RFS11 | GC Test of Cure | BOL_0001 | Sample is being submitted to confirm a patient’s gonorrhea infection has been cured. |
RFS16 | School-wide Event | BOL_0001 | Test is run as part of a school-wide STD screening event. This is different from screening/testing that occurs in a school-based health center. |
Rev. 05/17/2024